Featured content in this Issue:
- MAPS Invests in Numinus, Hopes to Offer Experiential Training for MDMA Therapists
- Long-Term Effects of Microdosing Remain Key Unknown; Cardiac Concern
- Psychedelics for SUDs: Policy, Not Just Pharmacology
- and more…
This content is for Pα+ Subscribers
This is the first issue of our Psychedelic Bulletin that’s exclusively for Pα+ subscribers. Head to our Join page to learn more, or sign in to your account.
